| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$27,618,890 |
|
|
|
Indirect Value
|
$97,197,843 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$124,816,733 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
See RemarksOfficer |
• • • |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,552,241 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-10-31 |
4 |
AB |
$13.35 |
$4,233 |
D/D |
317 |
115,621 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-04-19 |
4 |
D |
$64.43 |
$51,415 |
D/D |
(798) |
466,785 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-04-19 |
4 |
D |
$58.57 |
$49,843 |
D/D |
(851) |
653,649 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-05-06 |
4 |
D |
$66.26 |
$56,454 |
D/D |
(852) |
652,797 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-10-14 |
4 |
D |
$92.69 |
$78,972 |
D/D |
(852) |
610,189 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2021-05-06 |
4 |
D |
$115.71 |
$98,585 |
D/D |
(852) |
595,200 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2021-10-14 |
4 |
D |
$81.00 |
$69,093 |
D/D |
(853) |
594,347 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2018-06-01 |
4 |
D |
$73.73 |
$68,274 |
D/D |
(926) |
450,472 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2018-05-21 |
4 |
D |
$64.79 |
$63,883 |
D/D |
(986) |
451,398 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2017-06-01 |
4 |
D |
$56.61 |
$56,950 |
D/D |
(1,006) |
430,569 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-05-21 |
4 |
D |
$64.01 |
$68,619 |
D/D |
(1,072) |
516,447 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2017-05-21 |
4 |
D |
$57.47 |
$61,608 |
D/D |
(1,072) |
431,575 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2018-03-01 |
4 |
D |
$48.43 |
$53,951 |
D/D |
(1,114) |
448,955 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-06-01 |
4 |
D |
$54.93 |
$72,892 |
D/D |
(1,327) |
467,479 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2020-06-01 |
4 |
D |
$69.38 |
$92,553 |
D/D |
(1,334) |
611,041 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-05-21 |
4 |
D |
$59.50 |
$84,133 |
D/D |
(1,414) |
468,806 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-04-30 |
4 |
AB |
$10.37 |
$17,007 |
D/D |
1,640 |
162,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2004-10-31 |
4 |
A |
$3.51 |
$6,754 |
D/D |
1,924 |
25,034 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Business Operations |
• – – |
2005-05-02 |
4 |
A |
$3.43 |
$6,758 |
D/D |
1,968 |
27,002 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2007-10-31 |
4 |
B |
$6.92 |
$14,101 |
D/D |
2,038 |
96,164 |
2.74 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
163,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• – – |
2005-10-31 |
4 |
A |
$3.43 |
$8,832 |
D/D |
2,572 |
29,574 |
|
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-03-01 |
4 |
D |
$67.55 |
$189,275 |
D/D |
(2,802) |
467,670 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2019-03-05 |
4/A |
S |
$65.52 |
$189,353 |
D/D |
(2,890) |
467,583 |
0 |
- |
|
106 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
